Filippo Canducci was born in San Marino on July 8, 1976. In 1996, he obtained a B.S. degree at the Liceo Classico di San Marino (60/60). He was graduated in medicine (110/110) cum Laude, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy, in July 2001. In 2002, he obtained the National Medical Board. On March 7, 2005, he obtained a Ph.D. degree in pharmacology, chemotherapy, and microbiology from the University of Trieste, Trieste, Italy. In October 2008, he specialized in microbiology and virology from Università Vita-Salute San Raffaele, Milan, Italy. Dr. Canducci was an internal student in the Laboratory of Microbiology at the University of Salamanca from January 1998 till August 1998, where he studied Helicobacter pylori biology. In Rome, he was an internal student in medicine from 1998 to 2000, focusing on H. pylori therapy. He learned molecular biology techniques and the construction of recombinant human antibodies Fab fragments libraries displayed on the surface of filamentous phages. During his Ph.D., he studied the variability of RNA viruses in the Laboratory of Microbiology and Virology of the Università Vita-Salute San Raffaele. In 2003, Dr. Canducci isolated and characterized the SARS Coronavirus strain HSR1. Dr. Canducci has studied emerging respiratory viruses such as the human Metapneumovirus, the Coronaviruses NL-63 and HKU1, human Bocavirus, and SoIV Influenza A virus. Since 2003 Canducci has studied HIV-1 infection in vitro and in vivo by original phenotypic assays. He is now also leading a research group to study the role of microbes in atherosclerosis. Since 2002 he has been tutoring in microbiology, and since 2009 he has been appointed as a Contract Professor to teach microbiology at Università Vita-Salute San Raffaele. Since 2012 he works as an Assistant Professor of microbiology at the University of Insubria, Como, Italy.
Biography Updated on 7 June 2013